Medicus Pharma (MDCX) Shares Outstanding (Weighted Average) (2024 - 2025)

Medicus Pharma (MDCX) reported Shares Outstanding (Weighted Average) of $17.3 million for Q4 2025, up 79.68% on a YoY basis from $9.6 million in Q4 2024, and up 190.89% quarter-over-quarter from $5.9 million in Q3 2025.

Medicus Pharma (MDCX) Shares Outstanding (Weighted Average) (2024 - 2025) Analysis & Trends

Medicus Pharma has reported Shares Outstanding (Weighted Average) for 2 years, with the latest figure at $17.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 79.68% year-over-year to $17.3 million; the trailing twelve-month figure through Dec 2025 stood at $17.3 million (up 79.68% YoY), and the FY2025 full-year result was $17.3 million, up 79.68% from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 stood at $17.3 million, up from $5.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $17.3 million in Q4 2025, with the low at $5.9 million in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 1,818,692.66 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 894.50 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.41 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 1.77 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 2.47 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 540.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.24 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 5.69 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 2.04 Bn
10 Medicus Pharma 6.05 Mn 6.15 Mn - 17.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 17.28 Mn
Sep 30, 2025 5.94 Mn
Jun 30, 2025 14.28 Mn
Mar 31, 2025 12.24 Mn
Dec 31, 2024 9.62 Mn
Sep 30, 2024 9.51 Mn
Jun 30, 2024 8.17 Mn
Mar 31, 2024 8.08 Mn